C. Foggi

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.

R. Demicheli, G. Altavilla, V. Adamo, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Granular cell tumour of breast in a young man preoperatively diagnosed by fine needle aspiration (FNA) cytology

P. Foggi, A. Placidi, A. Aversa, 1995, Cytopathology : official journal of the British Society for Clinical Cytology.

Fulminant Hepatic Failure Caused by Diffuse Intrasinusoidal Metastatic Liver Disease: A Case Report

O. Martelli, R. Sarmiento, C. Foggi, 2000, Tumori.

Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.

D. Giannarelli, L. di Lauro, F. Calabresi, 1991, Seminars in oncology.

Lonidamine as a potentiating agent of the FAC regimen in the treatment of advanced breast cancer. Results of a multicentric randomized clinical study

R. Stolfi, D. Giannarelli, E. Cortesi, 1994 .

Is an Antiemetic Prophylactic Treatment Needed for Patients Submitted to Consecutive Days of 5-fluorouracil? An Observational Study

A. Favero, M. Maltoni, D. Amadori, 2001, Tumori.

Breast cancer and timing of surgery during menstrual cycle: a 5‐year analysis of 248 premenopausal women

M. Milella, F. Cognetti, A. Fabi, 1999, Breast Cancer Research and Treatment.